DEB-TACE-HAIC combined with donafenib and camrelizumab in the treatment of unresectable hepatocellular carcinoma: a multicenter retrospective study.

Zepsun (donafenib) - Suzhou Zelgen

AiRuiKa (camrelizumab) - Elevar Therapeutics

http://www.ncbi.nlm.nih.gov/pubmed/42292418

Feng Xiong; Hong Ren; Jian Long; Ruidong Wang; Shangbo Shi; Wei Li; Xinyi Fang; Xuexian Zhang; Yuanjin Ma

Jun 16, 2026